Olympus UK & Ireland

What Olympus UK & Ireland does

Olympus UK & Ireland operates as the British and Irish operating subsidiary of Olympus Europa SE & Co. KG, which is itself controlled by Olympus Corporation (TYO: 7733). The legal entity, KeyMed (Medical and Industrial Equipment) Limited, was acquired by Olympus in 1987 and is headquartered at KeyMed House, Stock Road, Southend-on-Sea, with additional sites in Dublin (KeyMed Ireland Limited), Plymouth, and Bolton. The subsidiary markets and sells medical endoscopy systems and related equipment across English, Irish, Scottish, and Welsh markets, while also contributing to the development and manufacturing of medical and industrial equipment for worldwide distribution.

The business is anchored in Olympus' Medical Systems division, offering a portfolio that includes the EVIS X1, EVIS LUCERA ELITE, EVIS EXERA III, VISERA ELITE, and VISERA Series endoscopic video platforms, the ORBEYE 4K 3D surgical microscope, the THUNDERBEAT integrated surgical energy device, Narrow Band Imaging (NBI) technology, and the OLYSENSE CAD/AI software platform acquired and developed following the 2022 Odin Vision cloud-AI acquisition. Endoscopic products serve eight medical specialties: Gastroenterology, ENT, General Surgery, Gynecology, Neurosurgery, Pulmonology, Thoracic Surgery, and Urology. Olympus holds approximately 70% global market share in gastrointestinal endoscopic equipment and maintains an installed base of approximately 15,000 patents.

Revenue is generated primarily through direct B2B enterprise sales of hardware (endoscopy systems, surgical energy devices, surgical microscopes), supplemented by professional services revenue from medical equipment repair (including at the Coimbra facility processing 15,000-30,000 items annually), training and education services through the Continuum platform, and warranty/service contracts. Pricing is quote-based under multi-year enterprise contracts targeting NHS trusts, private hospitals, and individual healthcare specialists. Go-to-market is sales-led with direct enterprise field sales teams covering the four UK nations and the Republic of Ireland. The subsidiary benefits from full ISO 13485, ISO 9001, ISO 14001, ISO 45001, MDSAP, and CE marking certifications required for medical device commercialization.

Name

Olympus UK & Ireland

Legal name

KeyMed (Medical and Industrial Equipment) Limited

Website

https://olympus.co.uk

Company type

Private

Founded year

1919

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Olympus UK & Ireland is the British and Irish subsidiary of Olympus Corporation, selling and manufacturing medical endoscopy systems, surgical energy devices, and AI-enabled imaging platforms directly to hospitals and healthcare specialists across eight medical specialties.

Ownership category

akta.pro rank

Product category

Medical Endoscopy Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration) (HLACAPAJ)

Keywords

• Medical endoscopy systems
• Surgical imaging devices
• Minimally invasive treatment
• Endoscopic imaging technology
• Medical equipment manufacturing

Headquarters

HQ city

Southend-on-sea

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Medical Systems and Devices: Olympus generates revenue primarily through the sale of medical endoscopy systems, endoscopes, surgical energy devices, and related medical equipment. The company offers a comprehensive lineup of solutions for early diagnosis and minimally invasive therapy suitable for a range of diseases including Gastroenterology, ENT, General Surgery, Gynecology, Pulmonology, Thoracic Surgery, and Urology.
2. Service and Repair: Olympus provides repair and service facilities for medical equipment, including the new repair center in Coimbra, Portugal, processing approximately 15,000 items annually with capacity to repair up to 30,000 items at peak.
3. Medical Training and Education: Training and education services through Continuum platform for medical professionals on Olympus medical systems and procedures.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Olympus UK & Ireland provides medical endoscopes, imaging systems, surgical energy devices, and surgical microscopes for healthcare professionals and medical facilities across the UK and Ireland. The company's Medical Systems division offers diagnostic and therapeutic technologies for early disease detection and minimally invasive treatment across gastroenterology, ENT, general surgery, gynecology, neurosurgery, pulmonology, thoracic surgery, and urology. It supplements hardware sales with repair services through European facilities and medical training via the Continuum education platform.

Product overview

Olympus UK & Ireland is a subsidiary of Olympus Europa SE & CO. KG, operating as a global medical technology company focused on early diagnosis and minimally invasive treatment. The company offers a comprehensive product portfolio centered around its Medical Systems division, which provides state-of-the-art diagnostic and therapeutic technologies including endoscopes (EVIS X1, EVIS LUCERA ELITE, EVIS EXERA III, VISERA ELITE, VISERA Series), surgical devices (ORBEYE surgical microscope with 4K 3D technology, THUNDERBEAT integrated surgical energy device), AI-powered solutions (OLYSENSE CAD/AI applications for computer-aided detection), and industrial products (IPLEX videoscopes, BX Series microscopes, FLUOVIEW confocal microscopes, VANTA XRF analyzers, LEXT OLS3000). The Medical Systems division is organized around key specialties: Gastroenterology, Ear/Nose/Throat, General Surgery, Gynecology, Neurosurgery, Pulmonology, Thoracic Surgery, and Urology. Olympus holds approximately 70% global market share in gastrointestinal endoscopic equipment and maintains over 100 years of innovation history.

Differentiator

Problem solved

Functional benefit

Products and services

• EVIS X1 Endoscopy System Flagship advanced endoscopy system for early diagnosis and minimally invasive treatment, offering enhanced imaging capabilities for gastroenterology and other endoscopic specialties. Sold to hospitals and medical facilities through direct enterprise field sales in the UK and Ireland.
• EVIS LUCERA ELITE High-end endoscopic video system with advanced imaging technology used in gastroenterology procedures and other endoscopic specialties.
• EVIS EXERA III Endoscopic video system platform offering versatile solutions for various medical specialties, including Narrow Band Imaging (NBI) technology.
• ORBEYE Surgical Microscope Surgical microscope incorporating 4K 3D video technology for neurosurgical procedures, enabling enhanced visualization during operations.
• THUNDERBEAT Surgical Energy Device Integrated surgical energy device combining ultrasound and bipolar energy for simultaneous cutting and coagulation during minimally invasive surgical procedures.
• OLYSENSE CAD/AI Applications AI-powered software platform for endoscopy, including CAD/AI applications for computer-aided detection of abnormalities and cloud-AI capabilities forming part of the Intelligent Endoscopy Ecosystem.
• VISERA ELITE Surgical Video Endoscope System Integrated surgical video endoscope system for minimally invasive surgical procedures, providing visualization across multiple surgical specialties.
• VISERA Series Integrated Video System Integrated video system platform for surgery providing comprehensive visualization solutions across surgical specialties.
• BioProtect Balloon Spacer Biodegradable rectal spacer balloon implant that provides consistent spacing between the prostate and other critical structures, protecting healthy tissues during prostate cancer radiation therapy.

Quantifiable outcome

• 70% global market share in gastrointestinal endoscopic equipment
• +3 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature7 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• BioProtectcoreStrategic or Co-development Partner · 26 May 2026Olympus signed a definitive agreement to acquire BioProtect Ltd. for $270 million. BioProtect develops the Balloon Spacer system for prostate cancer radiation therapy protection, with revenue of approximately $14.5 million in 2025 and 130 employees.
• Sony Olympus Medical Solutions Inc.coreTechnology or Integration · 1 January 2025Technology partnership for 4K resolution surgical endoscope system developed by Sony Olympus Medical Solutions Inc., launched in 2015.
• Odin VisioncoreStrategic or Co-development Partner · 1 January 2022Acquisition of cloud-AI endoscopy start-up Odin Vision in 2022, expanding Olympus' capabilities in AI-powered endoscopy solutions.
• MUT AcademyminorStrategic or Co-development Partner · 1 January 2022Olympus has been supporting the MUT Academy organization since the start of 2022. The academy encourages and supports young people with the transition from school to career for Hamburg students in city schools.
• ZUKE GreenminorStrategic or Co-development Partner · 1 January 2017Olympus is a partner of ZUKE Green, the first community for sustainable change in the healthcare sector in the DACH region. Since 2017, ZUKE Green has been promoting digital and sustainable procurement in healthcare.
• JOBLINGEminorStrategic or Co-development Partner · 1 January 2014Olympus has been a shareholder and founding partner of JOBLINGE gAG since September 2014 and started as a mentoring partner in 2016. JOBLINGE supports young people in Hamburg aged 16 to 25 in transitioning from school to career, with approximately 80% of participants successfully entering employment.
• Deutschlandstipendium / TH LübeckminorStrategic or Co-development Partner · 1 January 2013In collaboration with TH Lübeck (Lübeck University of Applied Sciences), Olympus has been supporting the Deutschlandstipendium scholarship program since 2013. Three students receive a monthly scholarship over three years, funded equally by the German government and Olympus.
• European Association of Urology (EAU)minorStrategic or Co-development PartnerThrough its partnership with the EAU, Olympus Surgical Technologies Europe (OSTE) has provided support in Africa for many years in the form of medical equipment. Partnership includes the Intensive Interactive Training Program (IITP) at Kilimanjaro Christian Medical Center (KCMC) in Tanzania.
• GESUNDES AFRIKAminorStrategic or Co-development PartnerOlympus supports the non-profit organization GESUNDES AFRIKA, which aims to strengthen the capacity of the health system on the African continent and improve access to basic health services through training and educating community health workers.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Ambu A/S: Danish company specializing in single-use endoscopes, particularly in pulmonology and ENT. Represents a disruptive model challenging reusable endoscopy incumbents like Olympus.
• Intuitive Surgical, Inc. Leader in robotic-assisted surgery with the da Vinci platform. Competes with Olympus in the broader surgical visualization space and represents the standard Olympus' Swan EndoSurgical endoluminal robotics effort is targeting.
• Boston Scientific Corporation: Major player in endoscopy-adjacent therapeutic devices and single-use endoscopes. Increasingly overlapping with Olympus in gastroenterology and urology procedural markets.

Direct peers

• Karl Storz SE & Co. KG: Germany-based privately held manufacturer of endoscopes and visualization systems for medicine and industry. Directly competes with Olympus across rigid and flexible endoscopy, serving the same surgical specialties in UK hospitals.
• PENTAX Medical (HOYA Corporation): HOYA's medical division manufactures flexible endoscopes and visualization platforms for GI, ENT, and pulmonology. Direct competitor in the same hospital procurement channels as Olympus UK & Ireland.
• Fujifilm Holdings Corporation: Direct competitor in GI endoscopy through its Fujifilm Healthcare division, offering endoscopic imaging systems and AI-enabled colonoscopy platforms. Competes head-to-head with Olympus EVIS X1 in gastroenterology departments.

Broad incumbents

• Medtronic plc: Global medical device leader with a GI business including endoscopic AI platforms (e.g., GI Genius). A broad incumbent investing in AI colonoscopy that directly threatens Olympus' 70% core market share.
• Stryker Corporation: Large diversified medical device company with surgical visualization, endoscopy, and surgical equipment offerings. Overlaps with Olympus in surgical devices and OR equipment through different go-to-market position.
• Johnson & Johnson (Ethicon): Through Ethicon and Auris Health, J&J is a major player in surgical endoscopy and robotic-assisted surgery. Competes with Olympus across general surgery and thoracic surgery workflows.

Regional players

• Smith & Nephew plc: UK-headquartered medical device company with surgical and orthopaedic portfolios. Overlaps with Olympus in surgical energy devices and operating room equipment, with strong UK hospital relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/olympus-corp
• Xx.com/OlympusMedUK

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olympus UK & Ireland